- Home
- GHRS vs MMD Comparison
GHRS vs MMD Comparison
Compare GHRS & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- MMD
- Stock Information
- Founded
- GHRS 2018
- MMD 2012
- Country
- GHRS Ireland
- MMD United States
- Employees
- GHRS N/A
- MMD N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- MMD Investment Managers
- Sector
- GHRS Health Care
- MMD Finance
- Exchange
- GHRS Nasdaq
- MMD Nasdaq
- Market Cap
- GHRS 470.3M
- MMD 439.8M
- IPO Year
- GHRS 2021
- MMD N/A
- Fundamental
- Price
- GHRS $9.62
- MMD $15.79
- Analyst Decision
- GHRS Strong Buy
- MMD
- Analyst Count
- GHRS 3
- MMD 0
- Target Price
- GHRS $35.67
- MMD N/A
- AVG Volume (30 Days)
- GHRS 71.7K
- MMD 74.7K
- Earning Date
- GHRS 11-14-2024
- MMD 01-01-0001
- Dividend Yield
- GHRS N/A
- MMD 4.88%
- EPS Growth
- GHRS N/A
- MMD N/A
- EPS
- GHRS N/A
- MMD N/A
- Revenue
- GHRS N/A
- MMD N/A
- Revenue This Year
- GHRS N/A
- MMD N/A
- Revenue Next Year
- GHRS N/A
- MMD N/A
- P/E Ratio
- GHRS N/A
- MMD N/A
- Revenue Growth
- GHRS N/A
- MMD N/A
- 52 Week Low
- GHRS $5.05
- MMD $14.30
- 52 Week High
- GHRS $14.99
- MMD $17.67
- Technical
- Relative Strength Index (RSI)
- GHRS 58.95
- MMD 21.30
- Support Level
- GHRS $8.50
- MMD $15.70
- Resistance Level
- GHRS $11.09
- MMD $16.77
- Average True Range (ATR)
- GHRS 0.90
- MMD 0.15
- MACD
- GHRS 0.14
- MMD -0.10
- Stochastic Oscillator
- GHRS 56.20
- MMD 8.26
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
MainStay MacKay DefinedTerm Municipal Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company may also invest in TOB (Tender Option Bonds) Floaters and TOB Residuals issued by the TOB Issuer. It evaluates its performance against Barclays Municipal Bond Index.